AngioDynamics, Inc. (FRA:UG2)

AngioDynamics Statistics

Total Valuation

AngioDynamics has a market cap or net worth of EUR 349.39 million. The enterprise value is 323.72 million.

Market Cap	349.39M
Enterprise Value	323.72M

Important Dates

The last earnings date was Tuesday, January 6, 2026.

Earnings Date	Jan 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.22M
Shares Outstanding	n/a
Shares Change (YoY)	+1.48%
Shares Change (QoQ)	+0.89%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	78.13%
Float	33.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.32
PB Ratio	2.30
P/TBV Ratio	3.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 156.70, with an EV/FCF ratio of -40.24.

EV / Earnings	-13.55
EV / Sales	1.23
EV / EBITDA	156.70
EV / EBIT	n/a
EV / FCF	-40.24

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.07.

Current Ratio	2.24
Quick Ratio	1.20
Debt / Equity	0.07
Debt / EBITDA	4.91
Debt / FCF	-1.26
Interest Coverage	-194.99

Financial Efficiency

Return on equity (ROE) is -15.26% and return on invested capital (ROIC) is -6.80%.

Return on Equity (ROE)	-15.26%
Return on Assets (ROA)	-4.60%
Return on Invested Capital (ROIC)	-6.80%
Return on Capital Employed (ROCE)	-10.45%
Revenue Per Employee	392,623
Profits Per Employee	-35,403
Employee Count	675
Asset Turnover	1.10
Inventory Turnover	2.12

Taxes

Income Tax	-1,725
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-30.89%
50-Day Moving Average	10.66
200-Day Moving Average	9.03
Relative Strength Index (RSI)	25.23
Average Volume (20 Days)	143

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.83

Income Statement

In the last 12 months, AngioDynamics had revenue of EUR 265.02 million and -23.90 million in losses. Loss per share was -0.58.

Revenue	265.02M
Gross Profit	144.64M
Operating Income	-17.82M
Pretax Income	-23.90M
Net Income	-23.90M
EBITDA	-129,360
EBIT	-17.82M
Loss Per Share	-0.58

Balance Sheet

The company has 35.91 million in cash and 10.17 million in debt, with a net cash position of 25.74 million.

Cash & Cash Equivalents	35.91M
Total Debt	10.17M
Net Cash	25.74M
Net Cash Per Share	n/a
Equity (Book Value)	152.07M
Book Value Per Share	3.66
Working Capital	77.09M

Cash Flow

In the last 12 months, operating cash flow was -4.83 million and capital expenditures -3.22 million, giving a free cash flow of -8.05 million.

Operating Cash Flow	-4.83M
Capital Expenditures	-3.22M
Free Cash Flow	-8.05M
FCF Per Share	n/a

Margins

Gross margin is 54.58%, with operating and profit margins of -6.73% and -9.02%.

Gross Margin	54.58%
Operating Margin	-6.73%
Pretax Margin	-9.02%
Profit Margin	-9.02%
EBITDA Margin	-0.05%
EBIT Margin	-6.73%
FCF Margin	n/a

Dividends & Yields

AngioDynamics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.48%
Shareholder Yield	-1.48%
Earnings Yield	-6.84%
FCF Yield	-2.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AngioDynamics has an Altman Z-Score of 1.63 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.63
Piotroski F-Score	4